venBio Global Strategic Fund IV, L.P. - SEC Form 4 Insider Trading Activity
10% Owner
Summary
Updated Aug 16, 2026
venBio Global Strategic Fund IV, L.P. has filed 1 SEC Form 4 filing across 1 company in the last 90 days - buying. Lifetime open-market purchases: $6.50M.
Trading Pattern
InsiderAlpha's records for venBio Global Strategic Fund IV, L.P. go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. The typical open-market purchase is $6.50M (1 buy totaling $6.50M). The largest single buy on record is $6.50M of ATTO in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role venBio Global Strategic Fund IV, L.P. has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- 10% Owner at Attovia Therapeutics, Inc. (ATTO) - 1 filing, 2026
Recent Transactions
4Companies - Last 90 Days
1- Attovia Therapeutics, Inc. (ATTO) - 1 filing, last 2026-08-10
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies venBio Global Strategic Fund IV, L.P. has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Colin Walsh - $12.54M of ATTO open-market activity in the last 12 months
- GOLDMAN SACHS GROUP INC - $12.54M of ATTO open-market activity in the last 12 months
- Redmile Group, LLC - $10.20M of ATTO open-market activity in the last 12 months
- Frazier Life Sciences XI, L.P. - $10.00M of ATTO open-market activity in the last 12 months
- Sanofi - $5.10M of ATTO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is venBio Global Strategic Fund IV, L.P.?
venBio Global Strategic Fund IV, L.P. is an investment firm - currently tracked as 10% Owner of Attovia Therapeutics, Inc. (ATTO). InsiderAlpha tracks every SEC Form 4 filing in real time.
How many SEC Form 4 filings has venBio Global Strategic Fund IV, L.P. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has venBio Global Strategic Fund IV, L.P. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($6.50M) and 0 open-market sales across all tracked filings.
Where can I see all of venBio Global Strategic Fund IV, L.P.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Get alerts when venBio Global Strategic Fund IV, L.P. files a new Form 4
Track every insider buy in real time, with AI-scored daily trade ideas and 10b5-1 plan flags.
Free during early access · No credit card required